Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy.

Mustjoki, S; Auvinen, K; Kreutzman, A; Rousselot, P; Hernesniemi, S; Melo, T; Lahesmaa-Korpinen, A-M; Hautaniemi, S; Bouchet, S; Molimard, M; Smykla, R; Lee, F Y; Vakkila, J; Jalkanen, S; Salmi, M; Porkka, K

Mustjoki, S; Auvinen, K; Kreutzman, A; Rousselot, P; Hernesniemi, S; Melo, T; Lahesmaa-Korpinen, A-M; Hautaniemi, S; Bouchet, S; Molimard, M; Smykla, R; Lee, F Y; Vakkila, J; Jalkanen, S; Salmi, M; Porkka, K.

Affiliation

Mustjoki S; Hematology Research Unit Helsinki, Department of Medicine, Division of Hematology, University of Helsinki and Helsinki University Central Hospital (HUCH), Helsinki, Finland.

Leukemia ; 27(4): 914-24, 2013 Apr.

Article in En | MEDLINE | ID: mdl-23192016

Subject(s)

Antineoplastic Agents/pharmacology; Pyrimidines/pharmacology; T-Lymphocytes, Cytotoxic/drug effects; Thiazoles/pharmacology; Adult; Cytokines/genetics; Dasatinib; Gene Expression Profiling; Humans; Immunophenotyping; K562 Cells; Male; T-Lymphocytes, Cytotoxic/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Thiazoles / T-Lymphocytes, Cytotoxic / Antineoplastic Agents Limits: Adult / Humans / Male Language: En Journal: Leukemia Year: 2013 Document type: Article

Fulltext

XML

PubMed Links

Search on Google